Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size |
A1 | 1 | 35 | F | Uterus | Endometrioid adenocarcinoma | 1 | T2N0M0 | II | Malignant | * |
A2 | 2 | 57 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | * |
A3 | 3 | 57 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
A4 | 4 | 38 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
A5 | 5 | 49 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 5*5 |
A6 | 6 | 47 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 9*9 |
A7 | 7 | 56 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 3*2.5*1.2 |
A8 | 8 | 53 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 6*4*4 |
A9 | 9 | 54 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 2.5*2*0.5 |
A10 | 10 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 11*10*4 |
A11 | 11 | 37 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 6*4.5*3 |
A12 | 12 | 53 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 9*8*8 |
A13 | 13 | 68 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 1 | T1bN0M0 | IB | Malignant | 7*4*4 |
B1 | 14 | 43 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 8*7*6 |
B2 | 15 | 49 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 2.5*1 |
B3 | 16 | 43 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 1 | T1aN0M0 | IA | Malignant | 2*2 |
B4 | 17 | 53 | F | Uterus | Endometrioid adenocarcinoma | 1 | T2N0M0 | II | Malignant | 9*9*4 |
B5 | 18 | 37 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 4*3*1.5 |
B6 | 19 | 63 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
B7 | 20 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | * |
B8 | 21 | 40 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | * |
B9 | 22 | 70 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
B10 | 23 | 33 | F | Uterus | Endometrioid adenocarcinoma | 1--2 | T1bN0M0 | IB | Malignant | 11*9*4 |
B11 | 24 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*3.5 |
B12 | 25 | 50 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*4*0.5 |
B13 | 26 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 4*3*2 |
C1 | 27 | 70 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
C2 | 28 | 50 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
C3 | 29 | 43 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T2N0M0 | II | Malignant | * |
C4 | 30 | 52 | F | Uterus | Endometrioid adenocarcinoma with degenerate | 2 | T1bN0M0 | IB | Malignant | * |
C5 | 31 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
C6 | 32 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC1 | Malignant | * |
C7 | 33 | 58 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T2N1M0 | IIIC1 | Malignant | * |
C8 | 34 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N1M0 | IIIC1 | Malignant | * |
C9 | 35 | 61 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T2N0M0 | II | Malignant | 3*2 |
C10 | 36 | 30 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
C11 | 37 | 57 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
C12 | 38 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
C13 | 39 | 58 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
D1 | 40 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
D2 | 41 | 74 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 3*3*2 |
D3 | 42 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | 2.5*2*1 |
D4 | 43 | 56 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1aN0M0 | IA | Malignant | 6*4.5*1.5 |
D5 | 44 | 70 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | 1.5*4.5*2 |
D6 | 45 | 52 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1bN0M0 | IB | Malignant | 4*3*2 |
D7 | 46 | 68 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T3aN0M0 | IIIA | Malignant | 8*6*4 |
D8 | 47 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | 9*5*3 |
D9 | 48 | 50 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3aN0M0 | IIIA | Malignant | 6*4*2.5 |
D10 | 49 | 58 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*3*3 |
D11 | 50 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 7*3*3 |
D12 | 51 | 79 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | 4*3*0.8 |
D13 | 52 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
E1 | 53 | 55 | F | Uterus | Endometrioid adenocarcinoma (interstitial) | * | T2N0M0 | II | Malignant | * |
E2 | 54 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | 6.0*4.0*1.5 |
E3 | 55 | 53 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | 5.0*3.0*1.0 |
E4 | 56 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 3.0*2.5*0.5 |
E5 | 57 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 4.0*4.0*0.8 |
E6 | 58 | 52 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1aN0M0 | IA | Malignant | 4.0*3.5*0.5 |
E7 | 59 | 50 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T2N0M0 | II | Malignant | 6.0*4.5*1.0 |
E8 | 60 | 52 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T1bN0M0 | IB | Malignant | 5.0*4.5*1.0 |
E9 | 61 | 53 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1bN0M0 | IB | Malignant | * |
E10 | 62 | 63 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 2--3 | T3aN0M0 | IIIA | Malignant | 9*3*2.5 |
E11 | 63 | 58 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1bN0M0 | IB | Malignant | 10*9*7 |
E12 | 64 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1bN1M0 | IIIC1 | Malignant | * |
E13 | 65 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1bN0M0 | IB | Malignant | * |
F1 | 66 | 48 | F | Uterus | Endometrioid adenocarcinoma with squamous differentiation | 2--3 | T1aN0M0 | IA | Malignant | * |
F2 | 67 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1aN0M0 | IA | Malignant | 3*2.5*1 |
F3 | 68 | 51 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1bN0M0 | IB | Malignant | * |
F4 | 69 | 58 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T3N1M0 | IIIC1 | Malignant | 3*2 |
F5 | 70 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN1M0 | IIIC1 | Malignant | * |
F6 | 71 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 6*4.5*1 |
F7 | 72 | 50 | F | Uterus | Endometrioid adenocarcinoma | 3 | T2N0M0 | II | Malignant | * |
F8 | 73 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | 6*4.5*1 |
F9 | 74 | 42 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1bN0M0 | IB | Malignant | 3.5*3.0*1 |
F10 | 75 | 48 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | * |
F11 | 76 | 38 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 5*4*3 |
F12 | 77 | 64 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | 4*4 |
F13 | 78 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3*2*1 |
G1 | 79 | 49 | F | Uterus | Endometrioid adenocarcinoma | 3 | T2N0M0 | II | Malignant | 5*5*4 |
G2 | 80 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 7*6*4 |
G3 | 81 | 60 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | 4*3*2.5 |
G4 | 82 | 51 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 8*4.5*4.5 |
G5 | 83 | 51 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 4*3 |
G6 | 84 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 4*2.5*1.5 |
G7 | 85 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3.5*3*1.2 |
G8 | 86 | 43 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1bN0M0 | IB | Malignant | 3.5*3*2.5 |
G9 | 87 | 66 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | * |
G10 | 88 | 63 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | * |
G11 | 89 | 55 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | * |
G12 | 90 | 52 | F | Uterus | Endometrioid adenocarcinoma with degenerate | 3 | T2bN0M0 | IIB | Malignant | * |
G13 | 91 | * | * | * | blank | * | * | * | * | * |
H1 | 92 | 42 | F | Uterus | Mucinous adenocarcinoma | 1 | T2N0M0 | II | Malignant | * |
H2 | 93 | 46 | F | Uterus | Mucinous adenocarcinoma | 2 | T3aN0M0 | IIIA | Malignant | * |
H3 | 94 | 48 | F | Uterus | Mucinous adenocarcinoma | 2 | T2bN0M0 | IIB | Malignant | * |
H4 | 95 | 52 | F | Uterus | Adenosquamous carcinoma | 3 | T1bN0M0 | IB | Malignant | * |
H5 | 96 | 69 | F | Uterus | Adenosquamous carcinoma | 3 | T1bN0M0 | IB | Malignant | * |
H6 | 97 | 63 | F | Uterus | Adenosquamous carcinoma | 3 | T1cN1M0 | IIIC1 | Malignant | * |
H7 | 98 | 45 | F | Uterus | Adenosquamous carcinoma | 3 | T1bN0M0 | IB | Malignant | * |
H8 | 99 | 53 | F | Uterus | Sarcomatoid carcinoma | * | T2N0M0 | II | Malignant | * |
H9 | 100 | 52 | F | Uterus | Sarcomatoid carcinoma | * | T2N0M0 | II | Malignant | * |
H10 | 101 | 52 | F | Uterus | Endometrial tissue | * | * | * | NAT | * |
H11 | 102 | 46 | F | Uterus | Endometrial tissue | * | * | * | NAT | * |
H12 | 103 | 54 | F | Uterus | Endometrial tissue | * | * | * | Normal | * |
H13 | 104 | * | * | * | blank | * | * | * | * |
Tissue Marker |